Invitae Corporation
NVTA
株式のランク
#35785
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
株価
$0.016
最終同期: 2024-03-11
時価総額
$3.27M
変化（1日）
-5.33%
変化（1年）
5,233.33%
国
US
取引 Invitae Corporation (NVTA)
カテゴリー
Healthcare
Invitae Corporation（NVTA）の発行済株式数
September 2023 時点の発行済株式数 275.60M
Invitae Corporation の最新の財務報告および株価によると、現在の発行済株式数は 275.60M です。December 2022 の終わりには、同社は 235.68M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Invitae Corporation（NVTA）の発行済株式数の履歴（2016 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 275.60M | 0.00% |
| 2023 | 275.60M | 16.94% |
| 2022 | 235.68M | 11.72% |
| 2021 | 210.95M | 56.74% |
| 2020 | 134.59M | 48.13% |
| 2019 | 90.86M | 36.12% |
| 2018 | 66.75M | 43.51% |
| 2017 | 46.51M | 40.20% |
| 2016 | 33.18M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 371.00M | 34.61% |
US
|
|
| 705.30M | 155.91% |
US
|
|
| 143.28M | -48.01% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 2.32% |
US
|
